1. Does the addition of oxaliplatin to preoperative chemoradiation benefit cT4 or fixed cT3 rectal cancer treatment? A subgroup analysis from a prospective study. Issue 12 (December 2016) Authors: Wiśniowska, K.; Nasierowska-Guttmejer, A.; Polkowski, W.; Michalski, W.; Wyrwicz, L.; Pietrzak, L.; Rutkowski, A.; Malinowska, M.; Kryński, J.; Kosakowska, E.; Zwoliński, J.; Winiarek, M.; Olędzki, J.; Kuśnierz, J.; Zając, L.; Bednarczyk, M.; Szczepkowski, M.; Tarnowski, W.; Paśnik, K.; Radziszew... Journal: European journal of surgical oncology Issue: Volume 42:Issue 12(2016:Dec.) Page Start: 1859 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The feasibility of short-course radiotherapy in a watch-and-wait policy for rectal cancer. (2nd September 2017) Authors: Bujko, K.; Pietrzak, L.; Partycki, M.; Szczepkowski, M.; Wyrwicz, L.; Rupiński, M.; Rutkowski, A.; Mróz, A. Journal: Acta oncologica Issue: Volume 56:Number 9(2017) Page Start: 1152 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗